Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207686
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207689
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178778
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178781
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185957
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185961
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185964
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772

Showing 11 to 20 of 57

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
STEGLUJAN 5MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133310
STEGLUJAN 15MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133307

Showing 1 to 2 of 2